Category: Accuray Inc.
Accuray shares are up today after the medical device company reports reduced losses and increased profit margins.
Accuray (NSDQ:ARAY) shares gained nearly 10% this morning after the medical device company reported lower fiscal 1st-quarter losses and an improved profit margin.
Sunnyvale, Calif.-based Accuray logged losses of $15.5 million, or -21¢ per share, on sales of $76.6 million for the 3 months ended Sept. 30, for a loss reduction of 35.6% on a sales decline of 7.4%.
Accuray CFO Derek Bertocci steps down to spend some time with his family, former Conceptus CFO Gregory Lichtwardt takes his place.
Radiosurgery systems maker Accuray gains more than 10% after releasing its 4th quarter earnings report.
Wall Street piled favor on California radiosurgery systems maker Accuray (NSDQ:ARAY) after the company narrowed losses in its 4th quarter, even as sales dropped by more than 15%.
Radiosurgical devices maker Accuray posted a 30% cut in sales during its 3rd quarter, but CEO Levine says he's "encouraged" by an uptick in order volume.
Medical device maker Accuray (NSDQ:ARAY) managed to get some Wall Street love after posting a rather harsh 3rd quarter earnings report this week, with investors likely reacting to news of promising order volume growth quarter-over-quarter.
Medical device company Accuray explains its action to remove 2 potentially defective components of its flagship CyberKnife radiosurgery platform.
Radiosurgery devices maker Accuray (NSDQ:ARAY) released an official statement on the recall of a pair of components of its CyberKnife radiosurgery systems, warning that the devices were not manufactured to standard.
Holaira says it raised $10 million from existing investors for its lung denervation system to treat chronic obstructive pulmonary disease.
Medical device company Holaira said it drummed up $10 million, changed its name and moved its headquarters.
Formerly known as Innovative Pulmonary Solutions, Holaira said it plans to use the Series C round to develop its minimally invasive devices to treat obstructive lung disease. All of Holaira's existing backers participated, namely Advanced Technology Ventures, Morgenthaler Ventures, Split Rock Partners, and Versant Ventures.